Skip to main content

Advertisement

Open Peer Review Reports for: Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Sep 2008 Submitted Original manuscript
5 Oct 2008 Reviewed Reviewer Report - John Doyle
13 Oct 2008 Reviewed Reviewer Report - Vaskar Saha
30 Oct 2008 Reviewed Reviewer Report - P Gaynon
3 Nov 2008 Reviewed Reviewer Report - Richard Maziarz
11 Nov 2008 Author responded Author comments - Virginie Gandemer
Resubmission - Version 2
11 Nov 2008 Submitted Manuscript version 2
13 Nov 2008 Reviewed Reviewer Report - Richard Maziarz
27 Nov 2008 Reviewed Reviewer Report - Vaskar Saha
2 Dec 2008 Reviewed Reviewer Report - John Doyle
12 Dec 2008 Author responded Author comments - Virginie Gandemer
Resubmission - Version 3
12 Dec 2008 Submitted Manuscript version 3
31 Dec 2008 Author responded Author comments - Virginie Gandemer
Resubmission - Version 4
31 Dec 2008 Submitted Manuscript version 4
7 Jan 2009 Author responded Author comments - Virginie Gandemer
Resubmission - Version 5
7 Jan 2009 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
12 Jan 2009 Author responded Author comments - Virginie Gandemer
Resubmission - Version 7
12 Jan 2009 Submitted Manuscript version 7
Publishing
13 Jan 2009 Editorially accepted
13 Jan 2009 Article published 10.1186/1471-2407-9-14

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement